β-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients

European Journal of Cancer

Volumn 36, Issue 3, 2000, Pages 330-334

  Hyltander, A ^a   Daneryd, P ^a   Sandstrom R ^a   Korner U ^a   Lundholm, K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adrenoceptor; Cachexia; Indirect calorimetry

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR; FATTY ACID; GLYCEROL; PROPRANOLOL; RECEPTOR SUBTYPE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CACHEXIA; CALORIMETRY; CANCER PATIENT; CARBON DIOXIDE EXCRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HEART RATE; HUMAN; LIPID OXIDATION; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CACHEXIA; CALORIMETRY, INDIRECT; CARBOHYDRATE METABOLISM; ENERGY METABOLISM; FEMALE; HEART RATE; HUMANS; MALE; NEOPLASMS; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; STATISTICS, NONPARAMETRIC; WEIGHT LOSS;

EID: 0033994155     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00273-7     Document Type: Article

References (32)

1. Warnold I, Lundholm K, Schersten T. Energy balance and body composition in cancer patients. Cancer Res 1978, 38, 1801-1807.
2. Hyltander A, Drott C, Korner U, Sandstrom R, Lundholm K. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 1991, 27A, 9-15.
3. Luketich JD, Mullen JL, Feurer ID, Sternlieb J, Fried RC. Ablation of abnormal energy expenditure by curative tumor resection. Arch Surg 1990, 125, 337-341.
4. Fredrix EW, Staal-van den Brekel AJ, Wouters EF. Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors. Cancer 1997, 79, 717-723.
5. Toomey D, Redmond HP, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995, 76, 2418-2426.
6. Moldawer LL, Georgieff M, Lundholm K. Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol 1987, 7, 263-274.
7. Drott C, Persson H, Lundholm K. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer. Clin Physiol 1989, 9, 427-439.
8. Drott C, Waldenstrom A, Lundholm K. Cardiac sensitivity and responsiveness to beta-adrenergic stimulation in experimental cancer and undernutrition. J Mol Cell Cardiol 1987, 19, 675-683.
9. Drott C, Ekman L, Holm S, Waldenstrom A, Lundholm K. Effects of tumor-load and malnutrition on myocardial function in the isolated working rat heart. J Mol Cell Cardiol 1986, 18, 1165-1176.
10. Drott C, Lundholm K. Cardiac effects of caloric restriction-mechanisms and potential hazards. Int J Obes Relat Metab Disord 1992, 16, 481-486.
11. Ransnas L, Drott C, Lundholm K, Hjalmarson A, Jacobsson B. Effects of malnutrition on rat myocardial beta-adrenergic and muscarinic receptors. Circ Res 1989, 64, 949-956.
12. Drott C, Lonnroth C, Lundholm K. Protein synthesis, myosin ATPase activity and myofibrillar protein composition in hearts from tumour-bearing rats and mice. Biochem J 1989, 264, 191-198.
13. Hyltander A, Korner U, Lundholm KG. Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. Eur J Clin Invest 1993, 23, 46-52.
14. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975, 31, 103-115.
15. Lusk G. The Elements of Science of Nutrition. 3rd edn. Philadelphia, WB Saunders, 1917.
16. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enterai Nutr 1977, 1, 11-22.
17. Staal-van den Brekel AJ, Schols AM, Dentener MA, ten Velde GP, Buurman WA, Wouters EF. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 1997, 76, 1630-1635.
18. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 1984, 53, 1265-1273.
19. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizzonite R, Lundholm K. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991, 51, 415-421.
20. Fujiki F, Mukaida N, Hirose K, et al. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer. Cancer Res 1997, 57, 94-99.
21. Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994, 54, 5602-5606.
22. Karlberg I, Edstrom S, Ekman L, Johansson S, Schersten T, Lundholm K. Metabolic host reaction in response to the proliferation of nonmalignant cells versus malignant cells in vivo. Cancer Res 1981, 41, 4154-4161.
23. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987, 238, 519-521.
24. Gelin JL, Moldawer LL, Iresjo BM, Lundholm KG. The role of the adrenals in the acute phase response to interleukin-1 and tumor necrosis factor-alpha. J Surg Res 1993, 54, 70-78.
25. Michie HR, Majzoub JA, O'Dwyer ST, Revhaug A, Wilmore DW. Both cyclooxygenase-dependent and cyclooxygenase-independent pathways mediate the neuroendocrine response in humans. Surgery 1990, 108, 254-259; 259-261.
26. Drott C, Svaninger G, Lundholm K. Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients. Ann Surg 1988, 208, 645-650.
27. Lindmark L, Bennegard K, Eden E, Svaninger G, Ternell M, Lundholm K. Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight. Ann Surg 1986, 204, 628-636.
28. Bennegard K, Lundgren F, Lundholm K. Mechanisms of insulin resistance in cancer associated malnutrition. Clin Physiol 1986, 6, 539-547.
29. Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K. Metabolic balance across the leg in weight-losing cancer patients compared to depleted patients without cancer. Cancer Res 1982, 42, 4293-4299.
30. Lundholm K, Bennegard K, Eden E, Svaninger G, Emery PW, Rennie MJ. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res 1982, 42, 4807-4811.
31. Daneryd P, Svanberg E, Korner U, et al. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res 1998, 58, 5374-5379.
32. Persson H, Bennegard K, Lundberg PA, Svaninger G, Lundholm K. Thyroid hormones in conditions of chronic malnutrition. A study with special reference to cancer cachexia. Ann Surg 1985, 201, 45-52.